NUSVSRXO• 12 Months (Normalized)
NUS vs RXO (Nu Skin Enterprises Inc. vs RXO Inc.)
Showing Closing Date Range from Oct 7, 2025 to Oct 7, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
NUS Performance $4.8
-56.8%
Nu Skin Enterprises Inc.
Normalized Baseline0.00%
RXO Performance $28.36
+68.01%
RXO Inc.
Normalized Baseline0.00%
Alpha Spread Margin RXO LEADS
-124.81 pts
RXO outperforming by 124.81 percentage points
NUSRXO
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
NUS RXO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(246 dates)
| Date | NUS Price | NUS Gain (%) | RXO Price | RXO Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 07, 2026 | $4.80 | -56.80% | $28.36 | +68.01% | -124.81% |
| Oct 06, 2026 | $4.74 | -57.34% | $28.54 | +69.08% | -126.42% |
| Oct 05, 2026 | $4.63 | -58.33% | $28.65 | +69.73% | -128.06% |
| Oct 02, 2026 | $4.61 | -58.51% | $23.38 | +38.51% | -97.02% |
| Sep 24, 2026 | $4.62 | -58.42% | $- | - | |
| Sep 23, 2026 | $4.61 | -58.51% | $19.88 | +17.77% | -76.28% |
| Sep 21, 2026 | $4.68 | -57.88% | $19.72 | +16.82% | -74.70% |
| Sep 18, 2026 | $4.58 | -58.78% | $20.26 | +20.02% | -78.80% |
| Sep 17, 2026 | $4.60 | -58.60% | $20.15 | +19.37% | -77.97% |
| Sep 16, 2026 | $4.58 | -58.78% | $19.08 | +13.03% | -71.81% |
| Sep 15, 2026 | $4.74 | -57.34% | $19.57 | +15.94% | -73.28% |
| Sep 14, 2026 | $4.87 | -56.17% | $19.46 | +15.28% | -71.45% |
| Sep 11, 2026 | $4.85 | -56.35% | $19.49 | +15.46% | -71.81% |
| Sep 10, 2026 | $4.88 | -56.08% | $19.51 | +15.58% | -71.66% |
| Sep 09, 2026 | $4.85 | -56.35% | $20.04 | +18.72% | -75.07% |
Page 1 of 17